Compare Norfolk Southern Corporation (NSC) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Norfolk Southern Corporation vs Summit Therapeutics Inc — how do they compare? Norfolk Southern Corporation trades at $333.48 (market cap $75.23B), while Summit Therapeutics Inc trades at $14.57 (market cap $10.48B). The key difference: Norfolk Southern Corporation is far larger — about 7.2× Summit Therapeutics Inc's market cap, and Norfolk Southern Corporation pays a 1.61% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| NSC | SMMT | |
|---|---|---|
Market Cap | $75.23B | $10.48B |
Sector | Technology | Health |
52-Week High | $340.16 | $29.32 |
52-Week Low | $272.35 | $13.05 |
Enterprise Value | $90.99B | $9.90B |
Dividend Yield | 1.61% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Norfolk Southern Corporation
Norfolk Southern Corporation is a major North American railroad company operating one of the largest freight rail networks in the eastern United States. The company transports a diverse range of commodities, including coal, intermodal containers, and various industrial products. NSC is a critical link in the nation's supply chain, providing efficient, long-haul transportation services to and from ports and industrial centers.
Read more on NSC →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
